What chances do children have against COVID-19? Is the answer hidden within the thymus?
Open Access
- 13 October 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (3) , 983-986
Abstract
A new type of coronavirus named as SARS-CoV-2 pandemic has begun to threaten human health. As with other types of coronaviruses, SARS-CoV-2 affects children less frequently, and it has been observed that the disease is mild. In the pathogenesis of a standard viral infection, the pathogen’s contact with the mucosa is initially followed by an innate immunity response. T cells are the primary decisive element in adaptive immunity capability. For this reason, the adaptive immune response mediated by the thymus is a process that regulates the immune response responsible for preventing invasive damage from a virus. Regulatory T cells (T-reg) are active during the early periods of life and have precise roles in immunomodulation. The thymus is highly active in the intrauterine and neonatal period; it begins to shrink after birth and continues its activity until adolescence. The loss of T-reg function by age results in difficulty with the control of the immune response, increased inflammation as shown in coronavirus disease (COVID-19) as an inflammatory storm. Also, the thymus is typically able to replace the T cells destroyed by apoptosis caused by the virus. Thymus and T cells are the key factors of pathogenesis of SARS-CoV-2 in children. Conclusion: We speculated that thymus activity and T lymphocyte function in children protect them against the virus effects. Stimulating and preventing the inhibition of the thymus can be possible treatment components against COVID-19. What is Known: • The SARS-CoV-2 infection does not often progress with an invasive clinic in children. • Thymus activity and T lymphocyte functions are highly active in children. What is New: • Effective thymus activity and T lymphocyte function in children protect them against the invasive SARS-CoV-2 infection. • Stimulating and preventing the inhibition of the thymus can be possible treatment components against COVID-19.Keywords
This publication has 16 references indexed in Scilit:
- Leptin Function and Regulation2017
- Thymic Atrophy: Experimental Studies and Therapeutic InterventionsScandinavian Journal of Immunology, 2017
- Thymic involution beyond T-cell insufficiencyOncotarget, 2015
- Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune responseVirology, 2014
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for PathogenesisThe Journal of Infectious Diseases, 2013
- Changes in primary lymphoid organs with agingSeminars in Immunology, 2012
- The aging of the immune systemTransplant International, 2009
- Thymus Size at 6 Months of Age and Subsequent Child MortalityThe Journal of Pediatrics, 2008
- Immunosenescence of ageingThe Journal of Pathology, 2007
- The Thymus Is a Common Target Organ in Infectious DiseasesPLOS Pathogens, 2006